口服可乐定镇静策略减少新生儿脑病降温治疗中阿片类药物使用
该单中心观察性研究比较了缺氧缺血性脑病治疗性低温期间口服可乐定策略(CLON)与吗啡策略(MOR)对阿片类药物使用的影响。CLON组吗啡毫克当量/kg及补救阿片需求均低于MOR组(P < .001),血流动力学安全性和感知有效性非劣于MOR。
要点
- CLON组总吗啡毫克当量/kg和补救阿片需求均显著低于MOR组(P < .001)。
- CLON组多巴胺累积剂量更低,需第二种正性肌力药及氢化可的松治疗低血压的频率更低。
- MOR组治疗性低温期间呼吸频率较CLON组更低(P = .01)。
核心结论
- 口服可乐定镇静策略在维持感知有效性和血流动力学安全性的同时,可减少缺氧缺血性脑病治疗性低温期间阿片类药物和正性肌力药的需求。
研究设计与样本
- 2020年4月13日至2020年8月13日期间从MOR策略过渡为CLON策略;MOR组为2020年4月13日前接受治疗性低温的患儿,CLON组为2020年8月13日后接受治疗性低温的患儿。
- MOR组74例新生儿,CLON组25例新生儿,两组基线特征相似。
- 主要结局为总吗啡毫克当量/kg及补救吗啡毫克当量/kg,次要结局为血流动力学变化频率。
主要发现
- MOR组与CLON组需要补救镇静静脉输注的比例相似(21.6% vs 20%)。
- MOR组总吗啡毫克当量/kg及补救阿片需求(包括推注和输注)均高于CLON组(P < .001)。
- 随着治疗性低温天数增加,CLON组需要补救阿片类药物的患者比例从第1天的92%降至第3天的68%。
- MOR组多巴胺累积剂量更高,更频繁需要第二种正性肌力药和氢化可的松治疗低血压。
- MOR组治疗性低温期间呼吸频率低于CLON组(P = .01)。
临床怎么用
- 对于接受治疗性低温的缺氧缺血性脑病新生儿,可考虑采用口服可乐定为基础的镇静策略以减少阿片类药物和正性肌力药使用。
- 实施CLON策略时需监测血流动力学和呼吸频率等短期安全性指标。
局限性
- 本研究为单中心观察性研究,样本量有限(MOR组74例,CLON组25例),组间比较可能受时间趋势等混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether an enteral, clonidine-based sedation strategy (CLON) during therapeutic hypothermia (TH) for hypoxic-ischemic encephalopathy would decrease opiate use while maintaining similar short-term safety and efficacy profiles to a morphine-based strategy (MOR). STUDY DESIGN: This was a single-center, observational study conducted at a level IV neonatal intensive care unit from January 1, 2017, to October 1, 2021. From April 13, 2020, to August 13, 2020, we transitioned from MOR to CLON. Thus, patients receiving TH for hypoxic-ischemic encephalopathy were grouped to MOR (before April 13, 2020) and CLON (after August 13, 2020). We calculated the total and rescue morphine milligram equivalent/kg (primary outcome) and frequency of hemodynamic changes (secondary outcome) for both groups. RESULTS: The MOR and CLON groups (74 and 25 neonates, respectively) had similar baseline characteristics and need for rescue sedative intravenous infusion (21.6% MOR and 20% CLON). Both morphine milligram equivalent/kg and need for rescue opiates (combined bolus and infusions) were greater in MOR than CLON (P < .001). As days in TH advanced, a lower percentage of patients receiving CLON needed rescue opiates (92% on day 1 to 68% on day 3). Patients receiving MOR received a greater cumulative dose of dopamine and more frequently required a second inotrope and hydrocortisone for hypotension. MOR had a lower respiratory rate during TH (P = .01 vs CLON). CONCLUSIONS: Our CLON protocol is noninferior to MOR, maintaining perceived effectiveness and hemodynamic safety, with an apparently reduced need for opiates and inotropes.
引用
- Fribance H, Liang C, Lee CKK, et al. Oral Clonidine-Based Strategy to Reduce Opiate Use During Cooling for Neonatal Encephalopathy: An Observational Study. J Pediatr. 2024. PMID: 38889855. doi:10.1016/j.jpeds.2024.114158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。